Regional Scientific Director, Mid-Atlantic Region

Regional Scientific Director, Mid-Atlantic Region Employer Intellia Therapeutics Location Cambridge, MA Start date Jun 3, 2026 View more categories View less categories Discipline Administration , Clinical , Clinical Data , Clinical Trials , Science/R D , Immunology , Project Management Required Education Doctorate/PHD/MD Position Type Full time Hotbed Genetown , Best Places to Work Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We wantall ofour people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just "treat" people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How You Will Achieve More:

The Regional Scientific Director (Associate Director level) serves in a customer-facing medical role to establish trusted partnerships within the healthcare community covering Intellia's CRISPR-based, first-in-class gene editing programs. Key responsibilities include scientific exchange, medical education and insight identification with PIs, KOLs, healthcare multidisciplinary teams and referral HCPs. RSDs will support both the nex-z and lonvo-z programs.

Mid-Atlantic Region will include:

Maryland, DC, North Carolina, South Caroline, Virginia, Delaware, Charleston.

Responsibilities:

The RSDs will focus their engagement efforts to KOLs and trial sites providing the following: Scientific Engagement Activities Engagement with KOLs across ATTR amyloidosis and HAE within territory to provide education on our CRISPR gene editing platform and reactively educate on the MoA and clinical data on nex-z and lonvo-z. Understanding of patient journey at key centers and identification of site capabilities and preferences regarding gene editing. Development of individualized scientific engagement plans for key KOLs aligned with scientific narrative and medical strategy. Identify external insights and knowledge gaps through listening for key intelligence topics of interest and timely reporting via CRM Medical Congress attendance to enable KOL engagement, medical booth staffing, scientific session coverage, insights gathering and reporting Institutional presentations on Intellia scientific evidence, as appropriate. Clinical Trial Awareness and Enrollment Focused Activities Provide scientific support for Phase 3 clinical trials during site start up, activation and recruitment through scientific education and operational insights Establish, cultivate, and maintain scientific relationships with Investigators and study site teams Identify barriers to site activation and/or patient recruitment, and discuss solutions with Investigators, study site teams, and institutional administrative team members to address and remove these barriers. Escalate site feedback or concerns to Intellia clinical teams Develop a robust understanding of clinical practice and referral associated with gene editing therapies. Ensure compliance and high level of scientific integrity in all interactions, including completion of trainings on time and adherence to policies

About You:

Demonstrated success working in a highly matrixed, cross-functional environment. Ability to critically assess situations to prioritize the importance, urgency and risks, and present leadership with recommendations. Ability to anticipate change and to flexibly adapt to changing business needs. Self-starter and team player with a collaborative spirit and results orientation. Organized, able to multi-task to meet timelines in a fast-paced environment with strong attention to accuracy and detail. Excellent presentation, communication, and project management skills across a variety of interaction mediums including in person, digital, email, phone, etc. Ability to understand and clearly and effectively communicate complex scientific and medical information to both internal and external stakeholders. Excellent written and oral communication skills are imperative; strong interpersonal skills commensurate with the need to collaborate closely with partners, investigators, contractors, consultants, and team members across functions. Established track record of effective and influential oral presentations to both large and small audiences within the healthcare profession. Ability to complete required training, documentation, expense reporting, and other administrative tasks. Willingness and ability to travel 50-70% including overnight stays. Ability to manage a geographically assigned territory from a home-based office. Computer skills including Excel, Word, Power Point, Outlook, and programs such as Zoom are expected. Valid driver's license Doctorate level or terminal degree (Pharm.

D., Ph.D., M.D. or D.O.) 3+ years industry or related field experience. Extensive clinical trial experience including Phase 3 trials Prior pharmaceutical industry experience as a MSL/RSD with solid understanding of scientific exchange in the context of compliance/ regulated environment and robust experience supporting execution of clinical trial. Therapeutic knowledge in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine highly preferred. New product launch experience highly preferred. Ability to sit or stand for multiple hours at a computer Manual dexterity for keyboarding; may include repetitive movements #

LI-Remote EEOC Statement:

Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down. The base salary for this position is expected to range between $216,000.00 - $264,000.00 USD per year. The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors. Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company's discretion. For more information about Intellia's benefits, please click here . Company Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers. Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously. We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases. Change life stories with genome editing therapies!

Stock Symbol:

NTLA Company info Website http://intelliatx.com/ Phone (857) 285-6200 Location 40 Erie Street Cambridge Massachusetts 02139 United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert